Search Results - "van der Poel, C.L."

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay by Van der Poel, C L, Cuypers, H T, Reesink, H W, Weiner, A J, Quan, S, Di Nello, R, Van Boven, J J, Winkel, I, Mulder-Folkerts, D, Exel-Oehlers, P J

“…A new four-antigen recombinant immunoblot assay (4-RIBA) for confirmation of hepatitis C virus (HCV) C-100 enzyme-linked immunosorbent assay (ELISA) reactivity…”
Get more information

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs by Vrielink, H, Zaaijer, H L, Reesink, H W, van der Poel, C L, Cuypers, H T, Lelie, P N

“…Three commercially available 3rd-generation anti-HCV ELISAs (Abbott, Murex and Ortho) were evaluated in various serum panels: (A) blood donor samples (n = 403)…”
Get more information

Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands by Borkent-Raven, B.A., Janssen, M.P., Van Der Poel, C.L., De Wit, G.A., Bonsel, G.J., Van Hout, B.A.

“…BACKGROUND: To further reduce the risk of hepatitis B virus (HBV) transmission by blood transfusion, nucleic acid testing (NAT) can be employed. The aim of…”
Get full text

Hepatitis C virus six years on by van der Poel, C L, Cuypers, H T, Reesink, H W

Get more information

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays by Jongerius, J.M., Wester, M., Cuypers, H. T.M, van Oostendorp, W.R., Lelie, P.N., van der Poel, C.L., van Leeuwen, E.F.

“…BACKGROUND: Envelope mutant forms of hepatitis B virus (HBV), impairing HBV antibody recognition, have been reported with mutations in single or multiple sites…”
Get full text

Sexual transmission of hepatitis C virus by Bresters, D, Mauser-Bunschoten, E P, Reesink, H W, Roosendaal, G, van der Poel, C L, Chamuleau, R A, Jansen, P L, Weegink, C J, Cuypers, H T, Lelie, P N

“…We tested 50 heterosexual partners of hepatitis C viraemic (HCV) individuals, using second generation HCV antibody assays and a validated polymerase chain…”
Get more information

Infectivity of blood seropositive for hepatitis C virus antibodies by van der Poel, C L, Reesink, H W, Schaasberg, W, Leentvaar-Kuypers, A, Bakker, E, Exel-Oehlers, P J, Lelie, P N

“…Stored serum samples from 5150 blood product transfusions and 383 recipients were tested for antibodies to hepatitis C virus (anti-HCV) by a recombinant…”
Get more information

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus by Damen, M, Zaaijer, H L, Cuypers, H T, Vrielink, H, van der Poel, C L, Reesink, H W, Lelie, P N

“…In a confirmatory laboratory, the second-generation recombinant immunoblot assay (RIBA-2) was replaced by the third-generation RIBA (RIBA-3) in March 1993. The…”
Get more information

Evaluation of automated nucleic acid extraction devices for application in HCV NAT by Jongerius, J.M., Bovenhorst, M., Van Der Poel, C.L., Van Hilten, J.A., Kroes, A.C.M., Van Der Does, J.A., Van Leeuwen, E.F., Schuurman, R.

“…BACKGROUND: To further improve the safety of the blood supply, various national blood transfusion organizations presently use or are in the process of…”
Get full text

Look-back study of infectivity of anti-HCV ELISA-positive blood components by Vrielink, H, van der Poel, C L, Reesink, H W, Zaaijer, H L, Scholten, E, Kremer, L C, Cuypers, H T, Lelie, P N, van Oers, M H

“…The infectivity of blood components from donors who were later found to be anti-HCV ELISA-positive was investigated in recipients who were enrolled in a…”
Get more information

Nucleic acid testing: the international status of NAT by van der Poel, C.L.

Get full text

What Are the Consequences of Indeterminate Results in Confirmatory Tests for Antibodies against Transmissible Viruses by Vrielink, H., Van Der Poel, C.L.

Get full text

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients by Bresters, D, Zaaijer, H L, Cuypers, H T, Reesink, H W, Winkel, I N, van Exel-Oehlers, P J, van Drimmelen, A A, Jansen, P L, van der Poel, C L, Lelie, P N

“…To establish the value of the second-generation recombinant immunoblot assay (RIBA-2) and cDNA polymerase chain reaction (cDNA PCR) for confirmation of…”
Get more information

GB Virus Type C Viremia and Envelope Antibodies among Population Subsets in The Netherlands by Jongerius, J.M., Boland, G.J., van der Poel, C.L., Rasch, M.C., Italiaander, E., van der Reijden, J.J., Friedman, P.N., Cockerill, J.J., van Leeuwen, E.F., van Hattum, J.

“…Background and Objectives: Two new flaviviruses, hepatitis G virus and GB virus type C (GBV–C), are possible causative agents for non–A–E hepatitis. In this…”
Get full text

Evaluation of a New HTLV-I/II Polymerase Chain Reaction by Vrielink, H., Zaaijer, H.L., Cuypers, H.T.M., van der Poel, C.L., Woerdeman, M., Lelie, P.N., Winkel, C., Reesink, H.W.

“…Aim: Evaluation of a qualitative HTLV-I/Il DNA polymerase chain reaction (PCR) test for the detection of HTLV-I/II DNA (Roche Diagnostic Systems, Branchburg,…”
Get full text

GB Virus Type C Viremia and Envelope Antibodies among Population Subsets in The Netherlands by Jongerius, J.M., Boland, G.J., van der Poel, C.L., Rasch, M.C., Italiaander, E., van der Reijden, J.J., Friedman, P.N., Cockerill, J.J., van Leeuwen, E.F., van Hattum, J.

“…Background and Objectives: Two new flaviviruses, hepatitis G virus and GB virus type C (GBV‐C), are possibele causative agents for non‐A‐E hepatitis. In this…”
Get full text

Hepatitis C virus: epidemiology, transmission and prevention by van der Poel, C L, Ebeling, F

Get more information

Mother-to-infant transmission and hepatitis C virus by Reesink, H W, Wong, V C, Ip, H M, van der Poel, C L, van Exel-Oehlers, P J, Lelie, P N

Get more information

Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies by Vrielink, H, Reesink, H W, Zaaijer, H L, van der Poel, C L, Cuypers, H T, Lelie, P N

“…Assays that detect human T-lymphotropic virus type I and type II antibody (HTLV-I/II) are widely used in the routine screening of blood donors. Four…”
Get more information

Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies by Vrielink, H, van der Poel, C L, Reesink, H W

Get more information